The Resveratrol Study (Active Project – Recruiting)

Purpose: The purpose of this study is to examine whether daily supplementation of resveratrol would improve bone health in postmenopausal women.

Background: Menopause increases the risk of bone loss. Resveratrol is a natural antioxidant present in the human diet, found in foods such as red grapes, blueberries, and peanuts.

About the study: This 6-month intervention study is recruiting postmenopausal women who have not been diagnosed with osteoporosis. Participants will be asked to take either 500 mg of resveratrol or placebo capsules daily for 6 months. Additionally, participants will receive 500 mg of calcium plus 400 IU of vitamin D daily. Blood and urinary biomarkers of bone will be assessed at baseline, and after 3 and 6 months of the intervention. Bone density will be measured using dual-energy X-ray absorptiometry (DXA) at baseline and after 6 months. All supplements will be provided, and participants will be compensated up to $200 for completing the study. Participants will also receive a free report of the DXA results. More information is available, please reach out by email or phone for inquiry. Please contact 302-831-7218 or email at ChaiResearchLab@udel.edu.